Ontario continues to improve access to treatment for children and adolescents living with ADHD who are prescribed INTUNIV XR®*
Ontario publicly reimburses INTUNIV XR® (guanfacine hydrochloride extended-release tablets) for both adjunctive and monotherapy treatment of children and adolescents with ADHD
Other Articles in this Edition
New clinical practice guideline for complex ADHD in children and adolescents
Depression, Anxiety, and Irritability Mediate Suicidality in Children with ADHD
Parental education level affects children’s mental health
Is Sleep Deprivation Worse When You Have ADHD? Yes and No
How to be a People Person When You Have ADHD
7 Things to Consider When Co-parenting For a Special Needs Child
Integrative Management of ADHD
One day, doctors could prescribe video games for ADHD. Should insurers pay for them?